Authors: MARTIN SW BISHOP FE KERR BM MOOR M MOORE M SHEFFELS P RASHED M SLATTER JG BERTHONCEDILLE L LEPAGE F DESCOMBE JJ PICARD M BAILLIE TA LEVY RH

Citation: Sw. Martin et al., PHARMACOKINETICS AND METABOLISM OF THE NOVEL ANTICONVULSANT AGENT ,6-DIMETHYLPHENYL)-5-METHYL-3-ISOXAZOLECARBOXAMIDE (D2624) IN RATS AND HUMANS, Drug metabolism and disposition, 25(1), 1997, pp. 40-46

Authors: RIZZELLO F GIONCHETTI P FERRIERI A VENTURI A BRIGNOLA C PERUZZO S RAULE E DESCOMBE JJ PICARD M CAMPIERI M

Citation: F. Rizzello et al., RIFAXIMIN, A NONABSORBABLE ANTIBIOTIC IN TREATMENT OF STEROID-RESISTANT ULCERATIVE-COLITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, Gastroenterology, 112(4), 1997, pp. 1072-1072

Authors: LEPAGE F GILLARDIN JM TOMBRET F GIRARD P DESCOMBE JJ TANG C MATHER GG LEVY RH BAILLIE TA

Citation: F. Lepage et al., HUMAN AND RAT-METABOLISM OF D2916 AND ANTICONVULSANT PROPERTIES OF ITS METABOLITES, Epilepsia, 36, 1995, pp. 261-261

Authors: DESCOMBE JJ DUBOURG D PICARD M PALAZZINI E

Citation: Jj. Descombe et al., PHARMACOKINETIC STUDY OF RIFAXIMIN AFTER ORAL-ADMINISTRATION IN HEALTHY-VOLUNTEERS, International journal of clinical pharmacology research, 14(2), 1994, pp. 51-56